Severe COVID-19 virus reactivation following treatment for B cell acute lymphoblastic leukemia

Severe COVID-19 virus reactivation following treatment for B cell acute lymphoblastic leukemia

Abstract SARS-CoV-2 has infected millions of people worldwide, but little is known at this time about second infections or reactivation. Here, we report a case of a 55-year-old female undergoing treatment for CD20+ B cell acute lymphoblastic leukemia who experienced a viral reactivation after receiv...

Full description

Bibliographic Details
Main Authors: Guido Lancman, John Mascarenhas, Michal Bar-Natan
Format: Article
Language:English
Published: BMC 2020-10-01
Series:Journal of Hematology & Oncology
Subjects:
COVID-19
SARS-CoV-2
Reactivation
Rituximab
Cytarabine
Online Access:http://link.springer.com/article/10.1186/s13045-020-00968-1

Similar Items

Similar Items